{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,6,13]],"date-time":"2025-06-13T12:06:39Z","timestamp":1749816399314},"reference-count":51,"publisher":"Wiley","license":[{"start":{"date-parts":[[2015,9,1]],"date-time":"2015-09-01T00:00:00Z","timestamp":1441065600000},"content-version":"tdm","delay-in-days":3205,"URL":"http:\/\/doi.wiley.com\/10.1002\/tdm_license_1.1"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"DOI":"10.1111\/j.1742-1241.2006.01182.x","type":"journal-article","created":{"date-parts":[[2006,11,22]],"date-time":"2006-11-22T11:04:39Z","timestamp":1164193479000},"page":"22-26","source":"Crossref","is-referenced-by-count":7,"special_numbering":"supplement s151","title":["Refractory neurogenic detrusor overactivity"],"prefix":"10.1155","volume":"60","author":[{"given":"F.","family":"CRUZ","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"C.","family":"SILVA","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2006,11,22]]},"reference":[{"key":"10.1111\/j.1742-1241.2006.01182.x-BIB1|cit1","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1080\/10790268.2003.11753678","article-title":"Effect of controlled-release oxybutynin on neurogenic bladder function in spinal cord injury","volume":"26","author":"O\u2018Leary","year":"2003","journal-title":"J Spinal Cord Med"},{"key":"10.1111\/j.1742-1241.2006.01182.x-BIB2|cit2","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1080\/10790268.2004.11753751","article-title":"Efficacy and safety of tolterodine in people with neurogenic detrusor overactivity","volume":"27","author":"Ethans","year":"2004","journal-title":"J Spinal Cord Med"},{"key":"10.1111\/j.1742-1241.2006.01182.x-BIB3|cit3","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1016\/S1569-9056(05)80653-0","article-title":"Neurogenic bladder treatment by doubling the permissible anticholinergic dosage [abstract]","volume":"4","author":"Horstmann","year":"2005","journal-title":"Eur Urol"},{"key":"10.1111\/j.1742-1241.2006.01182.x-BIB4|cit4","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/S1569-9056(05)80415-4","article-title":"Evaluation of the effectiveness of the combination of two anticholinergic drugs to treat severe cases of neurogenic bladder [abstract]","volume":"4","author":"Schaefer","year":"2005","journal-title":"Eur Urol"},{"key":"10.1111\/j.1742-1241.2006.01182.x-BIB5|cit5","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1097\/00042307-200411000-00006","article-title":"Botulinum toxin in the management of lower urinary tract dysfunction: contemporary update","volume":"14","author":"Cruz","year":"2004","journal-title":"Curr Opin Urol"},{"key":"10.1111\/j.1742-1241.2006.01182.x-BIB6|cit6","doi-asserted-by":"crossref","first-page":"977","DOI":"10.1097\/01.ju.0000169481.42259.54","article-title":"Decreased sensory receptors P2X3 and TRPV1 in suburothelial nerve fibers following intradetrusor injections of botulinum toxin for human detrusor overactivity","volume":"174","author":"Apostolidis","year":"2005","journal-title":"J Urol"},{"key":"10.1111\/j.1742-1241.2006.01182.x-BIB7|cit7","doi-asserted-by":"crossref","first-page":"1873","DOI":"10.1097\/01.ju.0000177477.83991.88","article-title":"Effects of botulinum toxin B on refractory detrusor overactivity: a randomized, duble-blinded, placebo controlled, crossover trial","volume":"174","author":"Ghei","year":"2005","journal-title":"J Urol"},{"key":"10.1111\/j.1742-1241.2006.01182.x-BIB8|cit8","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1136\/jnnp.64.1.6","article-title":"A double blind, randomised, parallel group study to investigate the dose equivalence of Dysport\u00ae and Botox\u00ae in the treatment of cervical dystonia","volume":"64","author":"Odergen","year":"1998","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"10.1111\/j.1742-1241.2006.01182.x-BIB9|cit9","first-page":"547","article-title":"Botulinum toxin-A (BTA) in the treatment of neurogenic detrusor overactivity incontinence (NDOI) - a prospective randomized study to compare 30 vs. 10 injection sites [abstract]","volume":"24","author":"Karsenty","year":"2005","journal-title":"Neurourol Urodyn"},{"key":"10.1111\/j.1742-1241.2006.01182.x-BIB10|cit10","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1056\/NEJM200003023420918","article-title":"Treatment of neurogenic incontinence with botulinum toxin A","volume":"342","author":"Schurch","year":"2000","journal-title":"N Engl J Med"},{"key":"10.1111\/j.1742-1241.2006.01182.x-BIB11|cit11","doi-asserted-by":"crossref","first-page":"510","DOI":"10.1016\/j.eururo.2003.12.004","article-title":"European experience of 200 cases treated with botulinum-A toxin injections into the detrusor muscle for urinary incontinence due to neurogenic detrusor overactivity","volume":"45","author":"Reitz","year":"2004","journal-title":"Eur Urol"},{"key":"10.1111\/j.1742-1241.2006.01182.x-BIB12|cit12","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1002\/nau.20105","article-title":"Botulinum A toxin injections into the detrusor: an effective treatment in idiopathic and neurogenic detrusor overactivity","volume":"24","author":"Kessler","year":"2005","journal-title":"Neurourol Urodyn"},{"key":"10.1111\/j.1742-1241.2006.01182.x-BIB13|cit13","doi-asserted-by":"crossref","first-page":"984","DOI":"10.1097\/01.ju.0000169480.43557.31","article-title":"A comparison between the response of patients with idiopathic detrusor overactivity and neurogenic detrusor overactive to the first intradetrusor injection of botulinum-A toxin","volume":"174","author":"Popat","year":"2005","journal-title":"J Urol"},{"key":"10.1111\/j.1742-1241.2006.01182.x-BIB14|cit14","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1016\/j.eururo.2004.11.009","article-title":"Success of repeat detrusor injections of botulinum A toxin in patients with severe neurogenic detrusor overactivity and incontinence","volume":"47","author":"Grosse","year":"2005","journal-title":"Eur Urol"},{"key":"10.1111\/j.1742-1241.2006.01182.x-BIB15|cit15","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1097\/01.ju.0000162035.73977.1c","article-title":"Botulinum toxin type A is a safe and effective treatment for neurogenic urinary incontinence: results of a single treatment, randomized, placebo controlled 6\u2003month study","volume":"174","author":"Schurch","year":"2005","journal-title":"J Urol"},{"key":"10.1111\/j.1742-1241.2006.01182.x-BIB16|cit16","first-page":"39","article-title":"The treatment of detrusor hyperreflexia using botulinum A toxin in myelomeningocele patients unresponsive to anticholinergic","volume":"21","author":"Corcos","year":"2002","journal-title":"Neurourol Urodyn"},{"key":"10.1111\/j.1742-1241.2006.01182.x-BIB17|cit17","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1016\/S0302-2838(03)00136-2","article-title":"Botulinum-A toxin detrusor injection as a novel approach in the treatment of bladder spasticity in children with neurogenic bladder","volume":"44","author":"Schulte-Baukloh","year":"2003","journal-title":"Eur Urol"},{"key":"10.1111\/j.1742-1241.2006.01182.x-BIB18|cit18","doi-asserted-by":"crossref","first-page":"845","DOI":"10.1097\/01.ju.0000108892.35041.2d","article-title":"Botulinum-A toxin injection into the detrusor: a safe alternative in the treatment of children with myelomeningocele with detrusor hyperreflexia","volume":"171","author":"Riccabona","year":"2004","journal-title":"J Urol"},{"issue":"Suppl. 3","key":"10.1111\/j.1742-1241.2006.01182.x-BIB19|cit19","first-page":"671","article-title":"Botulinum-A toxin as an alternative treatment to bladder augmentation in children with neurogenic bladder due to myelomenigocele","volume":"3","author":"Altaweel","year":"2004","journal-title":"Eur Urol"},{"key":"10.1111\/j.1742-1241.2006.01182.x-BIB20|cit20","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1038\/sj.sc.3101318","article-title":"Muscular weakness as side effect of botulinum toxin injection for neurogenic detrusor overactivity","volume":"40","author":"Wyndaele","year":"2002","journal-title":"Spinal Cord"},{"issue":"Suppl. 3","key":"10.1111\/j.1742-1241.2006.01182.x-BIB21|cit21","first-page":"663","article-title":"Efficacy, safety and dosage of English botulinum toxin-A in neurogenic detrusor overactivity","volume":"3","author":"Del Popolo","year":"2004","journal-title":"Eur Urol"},{"key":"10.1111\/j.1742-1241.2006.01182.x-BIB22|cit22","doi-asserted-by":"crossref","first-page":"802","DOI":"10.1097\/01.ju.0000108844.10235.f1","article-title":"Botulinum toxin type B for type A resistant bladder spasticity","volume":"171","author":"Pistolesi","year":"2004","journal-title":"J Urol"},{"key":"10.1111\/j.1742-1241.2006.01182.x-BIB23|cit23","doi-asserted-by":"crossref","first-page":"804","DOI":"10.1097\/01.ju.0000108407.53880.6a","article-title":"Botulinum toxin type B for management of type A resistant neurogenic detrusor overactivity","volume":"171","author":"Reitz","year":"2004","journal-title":"J Urol"},{"key":"10.1111\/j.1742-1241.2006.01182.x-BIB24|cit24","doi-asserted-by":"crossref","first-page":"784","DOI":"10.1016\/j.eururo.2004.07.011","article-title":"Lack of ultrastructural detrusor changes following endoscopic injection of botulinum toxin type A in overactive neurogenic bladder","volume":"46","author":"Haferkamp","year":"2004","journal-title":"Eur Urol"},{"key":"10.1111\/j.1742-1241.2006.01182.x-BIB25|cit25","doi-asserted-by":"crossref","first-page":"444","DOI":"10.1159\/000020322","article-title":"Desensitization of bladder sensory fibers by intravesical resiniferatoxin, a capsaicin analog: long-term results for the treatment of detrusor hyperreflexia","volume":"38","author":"Silva","year":"2000","journal-title":"Eur Urol"},{"key":"10.1111\/j.1742-1241.2006.01182.x-BIB26|cit26","first-page":"1","article-title":"Effect of the intravesical resiniferatoxin instillation evaluated by the ice provocative urodynamic study","volume":"27","author":"Shin","year":"2005","journal-title":"Spinal Cord"},{"key":"10.1111\/j.1742-1241.2006.01182.x-BIB27|cit27","doi-asserted-by":"crossref","first-page":"640","DOI":"10.1016\/S0140-6736(05)63330-2","article-title":"Suppression of bladder hyperreflexia by intravesical resiniferatoxin","volume":"350","author":"Cruz","year":"1997","journal-title":"Lancet"},{"key":"10.1111\/j.1742-1241.2006.01182.x-BIB28|cit28","doi-asserted-by":"crossref","first-page":"2093","DOI":"10.1016\/S0022-5347(01)68164-3","article-title":"Urodynamic effects of intravesical resiniferatoxin in humans: preliminary results in stable and unstable detrusor","volume":"158","author":"Lazzeri","year":"1997","journal-title":"J Urol"},{"key":"10.1111\/j.1742-1241.2006.01182.x-BIB29|cit29","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1080\/003655998750015287","article-title":"Intravesical resiniferatoxin for the treatment of detrusor hyperreflexia refractory to capsaicin in patients with chronic spinal cord diseases","volume":"32","author":"Lazzeri","year":"1998","journal-title":"Scand J Urol Nephrol"},{"key":"10.1111\/j.1742-1241.2006.01182.x-BIB30|cit30","doi-asserted-by":"crossref","first-page":"1710","DOI":"10.1016\/S0022-5347(05)65183-X","article-title":"Intravesical capsaicin versus resiniferatoxin in patients with detrusor hyperreflexia: a prospective randomized study","volume":"167","author":"Giannantoni","year":"2002","journal-title":"J Urol"},{"key":"10.1111\/j.1742-1241.2006.01182.x-BIB31|cit31","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1046\/j.1464-410X.2003.04441.x","article-title":"Effectiveness of intravesical resiniferatoxin in treating detrsuor hyper-reflexia and external sphincter dyssynergia in patients with chronic spinal cord lesions","volume":"92","author":"Kuo","year":"2003","journal-title":"BJU Int"},{"key":"10.1111\/j.1742-1241.2006.01182.x-BIB32|cit32","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1097\/01.ju.0000132152.53532.5d","article-title":"Intravesical resiniferatoxin versus botulinum-A toxin injections for neurogenic detrusor overactivity: a prospective randomized study","volume":"172","author":"Giannantoni","year":"2004","journal-title":"J Urol"},{"key":"10.1111\/j.1742-1241.2006.01182.x-BIB33|cit33","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1097\/01.ju.0000100385.93801.d4","article-title":"Intravesical capsaicin versus resiniferatoxin for the treatment of detrusor hyperreflexia in spinal cord injured patients: a double-blind, randomized, controlled study","volume":"171","author":"De Seze","year":"2004","journal-title":"J Urol"},{"key":"10.1111\/j.1742-1241.2006.01182.x-BIB34|cit34","doi-asserted-by":"crossref","first-page":"770","DOI":"10.1111\/j.1464-410X.2003.04722.x","article-title":"Parallel changes in bladder suburothelial vanilloid receptor TRPV1 and pan-neuronal marker PGP9.5 immunoreactivity in patients with neurogenic detrusor overactivity after intravesical resiniferatoxin treatment","volume":"93","author":"Brady","year":"2004","journal-title":"BJU Int"},{"key":"10.1111\/j.1742-1241.2006.01182.x-BIB35|cit35","doi-asserted-by":"crossref","first-page":"650","DOI":"10.1016\/j.eururo.2005.04.012","article-title":"Urodynamic effect of intravesical resiniferatoxin in patients with neurogenicdetrusor overactivity of spinal origin: results of a double-blind randomized placebo-controlled trial","volume":"48","author":"Silva","year":"2005","journal-title":"Eur Urol"},{"key":"10.1111\/j.1742-1241.2006.01182.x-BIB36|cit36","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1046\/j.1464-410X.2001.02339.x","article-title":"A light and electron-microscopic histopathological study of human bladder mucosa after intravesical resiniferatoxin application","volume":"88","author":"Silva","year":"2001","journal-title":"BJU Int"},{"key":"10.1111\/j.1742-1241.2006.01182.x-BIB37|cit37","first-page":"507","volume-title":"Textbook of the Neurogenic Bladder","author":"Silva","year":"2004"},{"key":"10.1111\/j.1742-1241.2006.01182.x-BIB38|cit38","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1097\/00005392-200102000-00032","article-title":"Intravesical electromotive administration of oxybutynin in patients with detrusor hyperreflexia unresponsive to standard anticholinergics regimens","volume":"165","author":"Di Stasi","year":"2001","journal-title":"J Urol"},{"key":"10.1111\/j.1742-1241.2006.01182.x-BIB39|cit39","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1111\/j.1464-410X.1985.tb07023.x","article-title":"\u2018\u2018Clam\u201c ileocystoplasty for the treatment of refractory urge incontinence","volume":"57","author":"Mundy","year":"1985","journal-title":"Br J Urol"},{"key":"10.1111\/j.1742-1241.2006.01182.x-BIB40|cit40","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1111\/j.1464-410X.1995.tb07777.x","article-title":"Clinical outcome and quality of life following enteroscystoplasty for idiopathic detrusor instability and neurogenic bladder dysfunction","volume":"76","author":"Hasan","year":"1995","journal-title":"Br J Urol"},{"key":"10.1111\/j.1742-1241.2006.01182.x-BIB41|cit41","doi-asserted-by":"crossref","first-page":"672","DOI":"10.1016\/S0090-4295(98)00220-9","article-title":"Patient perspective of long-term outcome of augmentation cystoplasty for neurogenic bladder","volume":"52","author":"Herschorn","year":"1998","journal-title":"Urology"},{"key":"10.1111\/j.1742-1241.2006.01182.x-BIB42|cit42","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1046\/j.1464-410x.1998.00549.x","article-title":"Long-term results and complications of augmentation ileocystoplasty for idiopathic urge incontinence in women","volume":"81","author":"Awad","year":"1998","journal-title":"Br J Urol"},{"key":"10.1111\/j.1742-1241.2006.01182.x-BIB43|cit43","doi-asserted-by":"crossref","first-page":"1050","DOI":"10.1016\/S0022-5347(17)38985-1","article-title":"Bladder autoaugmentation: partial detrusor excision to augment the bladder without the use of bowel","volume":"142","author":"Cartwright","year":"1989","journal-title":"J Urol"},{"key":"10.1111\/j.1742-1241.2006.01182.x-BIB44|cit44","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1046\/j.1464-410x.1998.00474.x","article-title":"Detrusor myectomy for detrusor overactivity: a minimum 1-year follow-up","volume":"81","author":"Swami","year":"1998","journal-title":"Br J Urol"},{"key":"10.1111\/j.1742-1241.2006.01182.x-BIB45|cit45","doi-asserted-by":"crossref","first-page":"758","DOI":"10.1016\/S0022-5347(01)61761-0","article-title":"Enterocystoplasty or detrusor myectomy? Comparison of indications and outcomes for bladder augmentation","volume":"161","author":"Leng","year":"1999","journal-title":"J Urol"},{"key":"10.1111\/j.1742-1241.2006.01182.x-BIB46|cit46","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1002\/nau.1930120507","article-title":"Physiological considerations in the use of sacral anterior root stimulators","volume":"12","author":"Brindley","year":"1993","journal-title":"Neurourol Urodyn"},{"key":"10.1111\/j.1742-1241.2006.01182.x-BIB47|cit47","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1159\/000474466","article-title":"Sacral rhizotomies and electrical bladder stimulation in spinal cord injury. Part I: clinical and urodynamic analysis. Dutch Study Group on Sacral Anterior Root Stimulation","volume":"31","author":"Van Kerrebroeck","year":"1997","journal-title":"Eur Urol"},{"key":"10.1111\/j.1742-1241.2006.01182.x-BIB48|cit48","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1111\/j.1525-1594.2005.29043.x","article-title":"Spastic bladder and spinal cord injury: seventeen years of experience with sacral deafferentation and implantation of an anterior root stimulator","volume":"29","author":"Kutzenberger","year":"2005","journal-title":"Artif Organs"},{"key":"10.1111\/j.1742-1241.2006.01182.x-BIB49|cit49","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1038\/sj.sc.3101278","article-title":"Neuromodulation through sacral nerve roots 2 to 4 with a Fenetech-Brindley sacral posterior and anterior root stimulator","volume":"40","author":"Kirkham","year":"2002","journal-title":"Spinal Cord"},{"key":"10.1111\/j.1742-1241.2006.01182.x-BIB50|cit50","doi-asserted-by":"crossref","first-page":"1237","DOI":"10.1097\/01.ju.0000080710.32964.d0","article-title":"An artificial somatic - central nervous system - autonomic reflex pathway for controllable micturition after spinal cord injury: preliminary results in 15 patients","volume":"170","author":"Xiao","year":"2003","journal-title":"J Urol"},{"key":"10.1111\/j.1742-1241.2006.01182.x-BIB51|cit51","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1016\/j.eururo.2005.10.004","article-title":"Reinnervation for neurogenic bladder: historic review and introduction of a somatic-autonomic reflex pathway procedure for patients with spinal cord injury or spina bifida","volume":"49","author":"Xiao","year":"2006","journal-title":"Eur Urol"}],"container-title":["International Journal of Clinical Practice"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1742-1241.2006.01182.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/onlinelibrary.wiley.com\/wol1\/doi\/10.1111\/j.1742-1241.2006.01182.x\/fullpdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,1,28]],"date-time":"2022-01-28T06:05:03Z","timestamp":1643349903000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/j.1742-1241.2006.01182.x"}},"subtitle":["REFRACTORY NEUROGENIC DETRUSOR OVERACTIVITY"],"short-title":[],"issued":{"date-parts":[[2006,11,22]]},"references-count":51,"URL":"https:\/\/doi.org\/10.1111\/j.1742-1241.2006.01182.x","relation":{},"ISSN":["1368-5031"],"issn-type":[{"value":"1368-5031","type":"print"}],"subject":[],"published":{"date-parts":[[2006,11,22]]}}}